Published ahead of print on July 10, 2003, doi:10.1165/rcmb.2003-0156OC
© 2004 American Thoracic Society DOI: 10.1165/rcmb.2003-0156OC Role of Interleukin-4 in Resistance to Cryptococcus neoformans InfectionDepartment of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma Address correspondence to: Rebecca Blackstock, Ph.D., Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, P.O. Box 26901, Oklahoma City, OK 73190. E-mail: becky-blackstock{at}ouhsc.edu
The role of interleukin (IL)-4 in cryptococcal disease was studied in IL-4 knockout (IL-4KO) and wild-type (WT) mice infected with Cryptococcus neoformans isolates that vary widely in their virulence. Delayed-type hypersensitivity responses were reduced in IL-4KO mice following primary infection with either isolate. Splenic T helper 1 (Th1) cytokine responses were increased in the IL-4KO mice infected with the weakly virulent isolate (184A) but did not change during infection with the highly virulent isolate (NU-2). Th2 cytokine responses (IL-5, IL-10) were downregulated in the IL-4KO mice infected with either isolate. Survival after primary infection with either isolate was not influenced by the absence of IL-4. Fewer colony-forming units were found in the lungs of 184A-infected, IL-4KO mice as compared to WT mice, suggesting that some immunity had developed. IL-4KO mice, primed with small doses of cryptococcal antigen (CneF), had significantly enhanced delayed-type hypersensitivity responses after intravenous infection with 184A and were more resistant to infection compared with WT mice. Increased expression of IL-5 with decreased interferon-
Abbreviations: colony-forming units, cfu cell-mediated immunity, CMI cryptococcal culture filtrate antigen, CneF delayed-type hypersensitivity, DTH enzyme-linked immunosorbent assay, ELISA fetal bovine serum, FBS Hanks' balanced salt solution, HBSS interferon- This article has been cited by other articles:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||